Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • SolsenS Offline
    SolsenS Offline
    Solsen
    wrote on sidst redigeret af
    #246

    ...deals

    1 Reply Last reply
    0
    • nohopeN Offline
      nohopeN Offline
      nohope
      wrote on sidst redigeret af
      #247

      Ja, eller 2200

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #248

        Godt vi så ved at JW siger, at I ikke skal sælge 😉

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #249

          Vi ved at JW har ambition om at blive et stort pharma med Genmab a la Regeneron eller Amgen. Hhv $60 og $145 bn....

          1 Reply Last reply
          0
          • G Offline
            G Offline
            GeorgeBest
            wrote on sidst redigeret af
            #250

            Roche Pharma Day 2020 presentation https://www.roche.com/dam/jcr:c24e5b67-24be-4f06-9380-6c700540e4e9/en/irp20200914.pdf

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #251

              amyloidosis Research Consortium

              @Amyloidosis_ARC
              · 3 t
              Game changer for AL amyloidosis -Janssen Pharmaceutical has filed an application with the US Food and Drug Administration seeking approval for Darzalex Faspro to treat light chain (AL) amyloidosis. http://ow.ly/Di8a50Bq7Hg

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #252

                Mosunetuzumab and glofitamab (CD20xCD3)
                Potential first in class bispecifics in DLBCL and FL - se side 44 https://www.roche.com/dam/jcr:c24e5b67-24be-4f06-9380-6c700540e4e9/en/irp20200914.pdf

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  GeorgeBest
                  wrote on sidst redigeret af
                  #253

                  og igen side 66-68 / Roche har fart på, SC version præsenteres på ASH!

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #254

                    God morgen. 🙂

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #255

                      God morgen 🙂

                      1 Reply Last reply
                      0
                      • T Offline
                        T Offline
                        transalp
                        wrote on sidst redigeret af
                        #256

                        Go morgen.. 🙂

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #257

                          Genmab
                          @Genmab

                          Join us at ESMO20, for an oral presentation on phase 2 innovaTV 204 study evaluating the investigational tisotumab vedotin in patients with recurrent or metastatic #cervicalcancer. Visit our virtual booth to get more info. https://esmo.org/meetings/esmo-virtual-congress-2020

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #258

                            that link doesn't get you much, you may want to put the link to the tweet?

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #259

                              I was just wondering Helge, I don't know who you normally get the Symphony Health
                              data from, but should we expect 1 number for Dara, or a split in Dara IV and Dara Faspro?

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #260

                                Sorry..Link to tweet. https://twitter.com/Genmab/status/1305763362077319169

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #261

                                  I receive Symphony Health data from pharma- og biotech investors. I dont know anything about af a evnt. split in Dara IV and Dara Faspro.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #262

                                    ok. I guess we find out next week 😉

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #263

                                      Yes. 🙂

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #264

                                        could use some help on the translation of this chinese article on Amivantamab... https://med.sina.cn/article_detail_103_2_89109.html

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Plimsoller
                                          wrote on sidst redigeret af
                                          #265

                                          Sent you a PM E L.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger